Compounded GLP-1 Safety: OTP Filed a FOIA Request, Here’s What the Government Told Us
For as long as I’ve been covering compounded GLP-1s, the answer to this one question has remained elusive: where are pharmacies actually getting their active pharmaceutical ingredients (APIs)? The source of these raw ingredients has always been shrouded in mystery, and patient advocates like myself have spent years trying to untangle it. The question always comes back to one answer: industry trade secrets. This week, however, I did receive a little more info.
Keep reading with a 7-day free trial
Subscribe to On The Pen to keep reading this post and get 7 days of free access to the full post archives.